KRAS and ovarian mucinous neoplasm: BRAF and p53 mutations are frequently identified within mucinous borderline tumor components, while KRAS and PIK3CA mutations are more commonly identified within the mucinous ovarian carcinoma components of mucinous ovarian tumors (5, 6).